Cart
sales@molnova.com
C-Met inhibitor D9
CAS No. 299405-67-7
C-Met inhibitor D9( —— )
Catalog No. M36033 CAS No. 299405-67-7
C-Met inhibitor D9 is a c-Met kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 426 | In Stock |
|
| 10MG | 625 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1283 | In Stock |
|
| 100MG | 1758 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3515 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameC-Met inhibitor D9
-
NoteResearch use only, not for human use.
-
Brief DescriptionC-Met inhibitor D9 is a c-Met kinase inhibitor.
-
DescriptionC-Met inhibitor D9 is a c-Met kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
Recptorc-Met/HGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299405-67-7
-
Formula Weight293.32
-
Molecular FormulaC17H15N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(NC(CCC1=CC=CC=C1)=O)=C2C=3C(NC2=O)=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Grazoprevir
MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), 0.15 nM (gt2b), respectively.
-
Ningetinib
Ningetinib (CT053PTSA) is an orally bioavailable tyrosine kinase inhibitor with IC50s of <1.0, 1.9 and 6.7 nM for Axl, VEGFR2, and c-Met, respectively.
-
BMS-794833
BMS794833?is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM.
